16.12.2015 • News

Inovyn to Consolidate European Chloromethane Capacity

Inovyn, the 50:50 chlorvinyls joint venture of Ineos and Solvay, will shut its chloromethane plant in Runcorn, UK, from Mar. 1 2016 as it has decided to consolidate production at Tavaux, France, and Rosignano, Italy.

The company said the move is in response to declining demand in Europe. It does not expect to make any compulsory redundancies.

Inovyn CEO Chris Tane said the new operations strategy will ensure the company is best positioned to focus on and meet demand in core markets. “It will also significantly improve our cost base and help underpin our sustainable, competitive position as a European chloromethanes producer,” he added.

Closing the chloromethane plant also provides an opportunity for Inovyn to exploit the site’s increased availability of membrane chlorine capacity, the company said, without giving further details.

Inovyn said that, despite the closure, it would continue to offer the full range of methylene chloride grades, as well as chloroform, carbon tetrachloride and perchloroethylene.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read